Ayala Pharmaceuticals Inc (ADXS)

[terry hallinan]

Dilution should be the last option with so many other options at hand....

Are you then unaware that selling off pieces of the company is the greatest dilution possible unless it's the like of ADRO suckering a JNJ with its purloined IP?

I know, I know, false apostles of truth and beauty and other folderol would have you believe otherwise but it's plainly specious doctrine.

When Amgen "partnered," in actuality bought, Advaxis-NEO, all other cancer vaccine developments were depreciated.

Kindly note I don't propose ADXS was wrong to sell its crown jewel of the moment and I regard it as a true coup personally as well as surprising insight by a giant dumbo.

The risk in Advaxis-NEO is very high and the cost of development likewise.

You might want to compare to an even further out and far riskier development IMHO that is proceeding on a nearly parallel track with a beastly money-raising problem:

MabVax Stockholders Approve Remaining Proposal at Special Meeting of Stockholders

https://finance.yahoo.com/news/mabvax-stockholders-approve-remaining-proposal-180000158.html


Even with hefty backing from the Warren Buffett of Biotech, Phillip Frost, MBVX had to struggle for financing like ADXS before Dan O'Connor.

In case anyone cares, I have no recommendation on MBVX. I do have a small position in Phillip Frost's last big project that is beginning to show dumkopf's the error of their ways:

Opko Health's Biggest Believer: CEO Phillip Frost Puts His Money Where His Mouth Is

http://tinyurl.com/ybtmx6kn

The small dawning of realization of the folly of critics bears evidence of becoming a torrent of confessions.

Wish I could say the same of the ADXS sellouts who are making a vastly greater blunder IMO while shielding their eyes from bright sunlight.

Prolonged darkness does that to one.

Best, Terry